期刊名称 biomedicine & pharmacotherapy
期刊缩写 BIOMED PHARMACOTHER
学科分类 医学、生命科学、农学
出版周期 月刊
审稿速度 1.5 个月 （平均）
投稿命中率 62.5 % （均值)
期刊主页 http://www.sciencedirect.com/science/journal/07533322
ISSN 号 0753-3322
IF 趋势 2005 2006 2007 2008 2009 2010 2011 2012
2.069 1.526 1.418 2.198 2.238 2.208 2 2.068
被收录情况 1. Science Citation Index
2. Science Citation Index Expanded
3. Current Contents - Life Sciences
4. BIOSIS Previews
PubSci评语 审稿效率高，对医学生物材料细胞生物学方面的内容似乎有所偏好。论文需要有亮点。
期刊简介 Biomedical and pharmacotherapy是为数不多的站在基础科研和应用技术、生物和医学、治疗和病理描述领域前沿的期刊。关注的具体方向包括分子和细胞生物学、遗传性疾病、免疫学和免疫调节和化疗，尤其是一些特定主题，比如分化、药理毒理、临床前和临床药理学、药物对细胞的结构和功能元件的影响、正常和病理细胞的基因调控机制、病毒和寄生虫的作用研究以及相应的疾病治疗。
投稿注意事项 特别提醒：无版面费，彩页费不详。
一般注意事项：
Biomedicine & Pharmacotherapy comprises the following: editorials (three typewritten pages); short general reviews (seven pages); original articles (eight pages, four tables, four figures); correspondence (two pages, one table or one figure), notes, news, clinical studies; clinical trials; papers concerning biomedico-technology, biomedico-economy, biomedico-epistemology, biomedico-politics will also be published.
On submission of an article for publication, the author guarantees that the article is original, that it has not been submitted for publication to another journal, and that it has not been previously published. The authors are requested to submit four copies of their manuscript which will be sent to three referees. Upon acceptation, a diskette containing the final version of the article should be provided.
Original articles should, when possible, be set out under the following subheadings : Summary; Introduction; Materials and methods; Results; Discussion and Conclusion, References.
The author's hospital, institute, research center or university address should be given at the beginning of the article together with telephone/fax number and e-mail.
The Summary should consist of no more than 250 words stating the key points of the article. The summary should be written in a clear and concise style so that all readers, whatever their speciality or discipline, can understand them.
The authors are requested to supply three keywords at the end of the Summary.
Abbreviations should be avoided. If they are absolutely necessary, they should be explained in full at the bottom of the first page.
References: Each citation in the text corresponds to a reference in the bibliography; each reference is quoted in the text. The references must be numbered and listed in alphabetical order of the first author's surname. All references listed must be quoted in the text by the corresponding number (in square brackets). The complete list should be typed double spaced at the end of the paper. Journal titles should be abbreviated in accordance with the Index Medicus. Submitted manuscripts should be cited as 'in press' only if they have been officially accepted for publication. Otherwise, they should be cited in the text only, as 'unpublished results' or 'submitted for publication' or 'manuscript in preparation' following the author's names. All references should be presented using the following format (using the same punctuation):
Journal article
1 Eriguchi M, Mathe G. Control curve model for comparative phase Ill trials: heterogeneity of the population. Biomed Pharmacother 1986; 40: 143-59.
Chapter in book
2 Lee XJ. Phase II trials in cancer : present status and analysis methods. In: Mathe G, Reizenstein P, Dicato M, Eds. Clinical trials in oncology: ethics, errors, methods and results. Geneva: Bioscience Ediprint; 1986. p. 57-72.
Figures: Four copies of illustrations are required; these should be numbered consecutively. Photographs must be distinct and sent as glossy prints. Line drawings will only be accepted if they are well drawn and can be reduced to a single column width (75 mm). Lettering (in lower case), figures and symbols (within the figure itself) should be sufficiently large so that they are still 2 mm high when reduced. Legends describing the figures must be typed on a separate sheet.
Colour photographs will normally not be accepted, unless they are indispensable, in which case the authors will be required to pay the cost of their production.
Tables should be typed on separate sheets, numbered with Roman numerals and given a title. The editor can request that necessary modifications to the content and form of articles be made and will not accept the article for publication until the various instructions given above have been complied with.
Proofs will be sent to the author indicated on the title page. They should be carefully corrected and returned to the publisher within 48 hours after reception (preferably by fax). If this period is exceeded, the galleys will be proofread by the editorial staff of the publishing house only and printed without the author's corrections. Should substantial changes in the original manuscript be requested, they will be made at the author's expense. An order form for reprints (exceeding the 25 reprints free of charge) will accompany the proofs and should be returned to the publisher with the corrected proofs. A letter of copyright transfer will be sent to the author together with the proofs. It should be returned to the publisher, duly signed, together with the author's corrections.
As soon as the article is published, the author is considered to have transferred his rights to the publisher. Requests for reproduction should be sent to the publisher.
编辑部信息 所在地： 国家 法国
Founding Editor
G. Mathé
Hôpital Suisse, F-92130 Issy-les-Moulineaux, France
Editors-in-Chief
H. Tapiero
France
K D Tew
USA
G Bastist
Canada
Associate Editors
D. Machover
Hôpital Paul Brousse, F-94800 Villejuif, France
M. Eriguchi
Japan
A. Carpi
Italy
网友投稿经验整理：
审稿时间:约1个月 接收率：约75%
这个杂志速度很快，我9月12号投的，10月2号就接受了，没让修回，10月31号就online,建议投稿。
贡献者： 218.4.189.6
这个杂志投了3个月也没有消息，这个月来了以后居然接受了，但是转到她的姊妹篇杂志，不是SCI，大家不要上当，我撤稿了，不是SCI要了做什么？！！1
贡献者：221.224.9.35
审稿时间:约2个月 接收率：约50%
这个杂志蛮奇怪的，我七月底投稿，中间编辑让推荐审稿人，然后推荐完后，文章状态一直是with editor，一个月后给编辑发了封邮件问文章有没有进行审稿，编辑没理我，过了一周，再查看，文章直接接收了，整体还是挺快的，虽然之前很郁闷。
贡献者：218.247.217.176
刚在这个杂志中了一篇文章 用来大概3周的时间 好像没有请审稿人 后来去丁香园上看有的战友的意见 感觉很失望 因为有的战友被骗过 这个杂志很可能把已经接受的文章放到他的姊妹刊物当中 而这个刊物没有因子 但是看到这个杂志中国人发表的文章也挺多 感觉工作量也差不多 就等进一步的消息了
贡献者：
审稿时间:约2个月 接收率：约50%
这个杂志今年的效率比较快了。感觉实验做的内容不在于多，而在于能说清楚一个问题。
贡献者：story
